These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9933855)

  • 41. Haemolysis after treatment with intravenous immunoglobulin due to anti-A.
    Morgan S; Sorensen P; Vercellotti G; Zantek ND
    Transfus Med; 2011 Aug; 21(4):267-70. PubMed ID: 21605202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
    Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E
    Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pharmacokinetic/pharmacodynamic model for the action of anti-D immunoglobulin in effecting circulatory clearance of Rh D+ red cells.
    Chapman GE
    Transfus Med; 1996 Sep; 6(3):227-33. PubMed ID: 8885152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of naturally occurring Rh antibodies on the survival of serologically incompatible red cells.
    Contreras M; de Silva M; Teesdale P; Mollison PL
    Br J Haematol; 1987 Apr; 65(4):475-8. PubMed ID: 3107611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoclonal reagents for rhesus-D typing of Irish patients and donors: a review.
    Williams M
    Br J Biomed Sci; 2000; 57(2):142-9. PubMed ID: 10912289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 47. Some observations on D antigen expression of D-positive and 'weak D-positive' red cells as assessed by flow cytometry.
    Nelson M; Barrow LA; Popp H; Gibson J
    Vox Sang; 1995; 69(2):152-4. PubMed ID: 8585204
    [No Abstract]   [Full Text] [Related]  

  • 48. Free antibody after low dose Rh immunoprophylaxis.
    Coleman RJ; Liley AW; Pinder L; Woodfield DG
    N Z Med J; 1982 Jul; 95(711):449-51. PubMed ID: 6810247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density.
    Mota M; Fonseca NL; Rodrigues A; Kutner JM; Castilho L
    Vox Sang; 2005 Feb; 88(2):130-5. PubMed ID: 15720611
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations--a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases.
    Krause I; Wu R; Sherer Y; Patanik M; Peter JB; Shoenfeld Y
    Transfus Med; 2002 Apr; 12(2):133-9. PubMed ID: 11982967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Four examples of anti-TSEN and three of TSEN-positive erythrocytes.
    Storry JR; Lindsay G; Rolih S; Co A; Rodberg K; Harris T; Reid ME
    Vox Sang; 2000; 79(3):175-9. PubMed ID: 11111237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences].
    Chamouni P; Josset V; Bastit D; Tavolacci MP; Lenain P; Varin R; Czernichow P
    Transfus Clin Biol; 2005 Oct; 12(4):306-12. PubMed ID: 16169273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. When is an anti-D antibody not an anti-D antibody?
    Merron BM; Maguire K; Morris K
    Transfus Med; 2015 Apr; 25(2):115-7. PubMed ID: 25925731
    [No Abstract]   [Full Text] [Related]  

  • 54. Anti-A and anti-B: what are they and where do they come from?
    Branch DR
    Transfusion; 2015 Jul; 55 Suppl 2():S74-9. PubMed ID: 26174901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel?
    Vox Sang; 1982; 43(3):151-68. PubMed ID: 6815895
    [No Abstract]   [Full Text] [Related]  

  • 56. [Partial deletion of the D antigen in a family group. Determination of its antigenic density by flow cytometry].
    Hernández T; León G; Sánchez P
    Sangre (Barc); 1994 Apr; 39(2):139-43. PubMed ID: 7520193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of the polyethyleneglycol antiglobulin test in the detection and identification of erythrocyte antibodies].
    Jiménez Marco MT; Hernández Maraver D; Rodríguez de la Rua A; de la Cámara Mendizábal C; Canales Albendea M; Jiménez Yuste V; Hernández Navarro F
    Sangre (Barc); 1998 Feb; 43(1):21-4. PubMed ID: 9577178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Test for blood group incompatibility in pregnancy].
    Okubo M; Tate A; Maeda H; Suzuki M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():803-6. PubMed ID: 20942195
    [No Abstract]   [Full Text] [Related]  

  • 59. Red cell antibodies and low ionic strength: a study with enzyme-linked antiglobulin test.
    Leikola J; Perkins HA
    Transfusion; 1980; 20(2):224-8. PubMed ID: 6768174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of the DGTI workshop on the evaluation of the reactivity of monoclonal anti-D.
    Sonneborn HH; Darda C; Ernst M; Flegel WA; Helmbold W; Kasulke D; Kühnl P; Mueller-Eckhardt C; Northoff H; Poschmann A
    Beitr Infusionsther; 1992; 30():382-7. PubMed ID: 1284741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.